Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 214

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 214
---
30 was determined by senior management and the Board of Directors of Aptorum and DiamiR in direct discussions based on available quantitative and qualitative information regarding each of the companies, as well as the experience and judgement of management and the board of directors for each company. Management and the Board of Directors of Aptorum and DiamiR considered the following factors, among others: •The quoted market price of Aptorum Class A ordinary shares •The nature of and value ascribed to prior transactions involving the issuance by DiamiR of its common stock •Aptorum’s and DiamiR’s recent financing activities •Other publicly available information of Aptorum •The markets for DiamiR’s tests in development and their stage of development •The intellectual property and human and financial resources of each •Available information regarding Aptorum’s and DiamiR’s future plans •Observable valuations and transactions of similar companies •Anticipated risk factors Between May 12, 2025 and July 13, 2025, Aptorum and DiamiR, and their respective legal counsels, generally exchanged further internal information, including working capital needs, and conducted customary due diligence. The companies developed and reviewed further information regarding the valuation of comparable companies. On July 7, 2025, DiamiR entered into a financial advisory agreement with H.C. Wainwright & Co., LLC (“Wainwright”), with Wainwright to act as exclusive financial advisor to DiamiR in connection with the Merger. The companies did not exchange financial projections. Aptorum did not engage a financial advisor. Based on these activities, in the absence of material business developments affecting either company in the period, each companies’ senior management concluded that no adjustment to the estimated preliminary conversion ratio was necessary during the finalization of terms for the Merger Agreement. 105 Interests of Aptorum Directors, Officers and Affiliates in the Merger In considering the recommendation of the Aptorum Board with respect to issuing shares of Aptorum Delaware common stock in the Merger and the other matters to be acted upon by the Aptorum shareholders at the Special Meeting, the Aptorum shareholders should be aware that Aptorum directors and executive officers have interests in the Merger that are different from, or in addition to, the interests of Aptorum shareholders generally. These interests may present Aptorum directors and executive officers with actual or potential conflicts of interest. For example, Aptorum’s directors and officers will be eligible for continued indemnification and continued coverage under directors’ and officers’ liability insurance after the